Local Partner – Supernus Pharmaceuticals

At Supernus, we hold a fundamental belief that our science has the potential to improve the lives of people with Parkinson’s disease (PD). Our commitment to people with Parkinson’s and their care partners is reflected in all that we do. Our pipeline of development projects, along with our three currently available PD treatments, reflect our resolve to bring innovative solutions to the Parkinson’s community.


Click below to learn more about our available PD therapies.


Moving Day has raised nearly $45 million and brought more than 186,000 participants together.